Tower Research Capital (TRC)’s Arcellx ACLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,270
| Closed | -$261K | – | 5183 |
|
|
2026
Q1 | $261K | Buy |
2,270
+1,843
| +432% | +$163K | 0.01% | 1415 |
|
|
2025
Q4 | $27.8K | Sell |
427
-569
| -57% | -$45.4K | ﹤0.01% | 2856 |
|
|
2025
Q3 | $81.8K | Sell |
996
-5,147
| -84% | -$371K | ﹤0.01% | 2164 |
|
|
2025
Q2 | $405K | Buy |
6,143
+3,147
| +105% | +$196K | 0.01% | 1163 |
|
|
2025
Q1 | $197K | Sell |
2,996
-4,988
| -62% | -$338K | 0.01% | 1383 |
|
|
2024
Q4 | $612K | Buy |
7,984
+7,308
| +1,081% | +$631K | 0.01% | 924 |
|
|
2024
Q3 | $56.5K | Sell |
676
-3,963
| -85% | -$264K | ﹤0.01% | 2653 |
|
|
2024
Q2 | $256K | Buy |
4,639
+4,243
| +1,071% | +$231K | ﹤0.01% | 1883 |
|
|
2024
Q1 | $27.5K | Sell |
396
-4,794
| -92% | -$304K | ﹤0.01% | 2718 |
|
|
2023
Q4 | $288K | Buy |
5,190
+4,140
| +394% | +$187K | ﹤0.01% | 1801 |
|
|
2023
Q3 | $37.7K | Sell |
1,050
-9,200
| -90% | -$317K | ﹤0.01% | 2812 |
|
|
2023
Q2 | $324K | Buy |
10,250
+8,786
| +600% | +$336K | 0.01% | 1250 |
|
|
2023
Q1 | $45K | Buy |
1,464
+1,005
| +219% | +$30.5K | ﹤0.01% | 2579 |
|
|
2022
Q4 | $14K | Sell |
459
-3,130
| -87% | -$71.8K | ﹤0.01% | 3482 |
|
|
2022
Q3 | $67K | Buy |
3,589
+1,635
| +84% | +$31.3K | ﹤0.01% | 2892 |
|
|
2022
Q2 | $35K | Buy |
1,954
+1,307
| +202% | +$16.9K | ﹤0.01% | 3205 |
|
|
2022
Q1 | $9K | Buy |
+647
| New | +$10.8K | ﹤0.01% | 4423 |
|
Other funds holding ACLX
Tower Research Capital (TRC)'s ACLX Position: Q2 2026 in Review
Tower Research Capital (TRC) sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 2,270 shares — an estimated $261K sold.
Tower Research Capital (TRC) first reported a position in ACLX in Q1 2022 and held it in 17 quarters. The position peaked at $612K in Q4 2024. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.
- Tower Research Capital (TRC) reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,270 Arcellx shares in Q2 2026, an estimated $261K.
- Tower Research Capital (TRC) first reported a position in Arcellx in Q1 2022 and held it in 17 quarters.
- Tower Research Capital (TRC)'s Arcellx position peaked at $612K in Q4 2024.
- 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.